Scaling a global leader in clinical pharmacology and bioanalytical sciences

Celerion is a global leader in early-phase clinical research, specializing in complex studies including first-in-human dose escalation, cardiac safety, bioequivalence, and drug-drug interaction, as well as advanced bioanalytical sciences, serving the world's leading pharmaceutical and biotechnology companies from facilities across North America and Europe. Celerion is focused on expanding relationships with major biopharmaceutical customers, further building out its bioanalytical capabilities, and investing in internally developed technologies to deliver high-quality, reliable clinical trial data.